请输入关键词查询对齐语料

  1. 输入关键词后点击检索按钮可查询指定关键词在语料中的对应情况
  2. 选择语种可限定关键词的语言，当前支持中文和英文，默认选择中文
  3. 主题选项中可限定检索语料的文章主题范围，默认全部主题
  4. 主题选项中可限定检索语料的文本类型范围，默认全部类型
  5. 在结果列表中，点击操作栏中的“查看中文全文”或“查看英文全文”按钮可查看该句所在的中文语料全文
句对齐列表 共 16269 个结果  
序号 中文 英文 操作
2031 然而，疫苗接种策略的有效性取决于其所覆盖的人数，这就是为什么COVAX机制如此重要。 However, a vaccination strategy is only as effective as the number of people it reaches, which is why the COVAX facility is so critical.
2032 获得疫苗提供的保护不应受到限制或约束。 Access to the protection offered by a vaccine should not be limited or restricted.
2033 所有国家，无论收入水平如何，都应该平等获得这些救命的疫苗”。 All countries, regardless of income levels, should have equal access to these life-saving vaccines.”
2034 2021年COVID-19疫苗的交付将是有史以来新型疫苗在全球最迅速和最大规模的部署。 The delivery of COVID-19 vaccines during 2021 will be the fastest and largest global deployment of novel vaccines in history.
2035 COVAX机制的目标是，到2021年底，向所有参与国提供至少20亿剂安全、有效和有质量保证的疫苗，其中除了较富裕国家，要向具有AMC资格的92个国家和经济体提供至少13亿剂疫苗。 The COVAX Facility aims, by the end of 2021, to deliver at least 2 billion doses of safe, effective and quality-assured vaccines to all participating countries, including at least 1.3 billion doses to the 92 AMC-eligible countries and economies, at the same time as wealthier nations.
2036 2022年7月8日的补充说明： Additional note of 8 July 2022:
2037 赔偿规划将为具有AMC资格的国家和经济体中符合条件的个人提供一个快速、公平、健全和透明的流程，在2023年6月30日（原新闻稿中所列日期为2022年6月30日）之前对COVAX机制分发的COVID-19疫苗有关的罕见但严重的不良事件进行赔偿。 The compensation programme will offer eligible individuals a fast, fair, robust and transparent process to receive compensation for rare but serious adverse events associated with COVID-19 vaccines earmarked for delivery through the COVAX Facility for use in AMC-eligible countries and economies until 30 June 2023 (as opposed to 30 June 2022 indicated in the original press release).
2038 关于COVAX机制 ABOUT the COVAX Facility
2039 由全球疫苗免疫联盟管理的COVAX机制是获取COVID-19工具（ACT）加速计划中COVAX支柱的一个关键部分。 The Gavi-administered COVAX Facility forms a key part of the COVAX pillar (COVAX) of the Access to COVID-19 Tools (ACT) Accelerator, a ground-breaking global collaboration to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
2040 ACT加速计划是一个突破性的全球合作项目，旨在加速开发、生产和公平获得COVID-19检测工具、治疗药物和疫苗。 COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and WHO, working in partnership with developed and developing country vaccine manufacturers.